Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia-Reference-Cited by-同舟云学术

Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia

Published:2017-01-16 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Argibay Bárbara,Trekker Jesse,Himmelreich Uwe,Beiras Andrés,Topete Antonio,Taboada Pablo,Pérez-Mato María,Vieites-Prado Alba,Iglesias-Rey Ramón,Rivas José,Planas Anna M.,Sobrino Tomás,Castillo José,Campos Francisco

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep40758.pdf

Reference98 articles.

1. Feigin, V. L. et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383, 245–254 (2010).

2. Howard, G. & Goff, D. C. Population shifts and the future of stroke: forecasts of the future burden of stroke. Ann N Y Acad Sci 1268, 14–20 (2012).

3. Paul, G. & Anisimov, S. V. The secretome of mesenchymal stem cells: potential implications for neuroregeneration. Biochimie 95, 2246–2256 (2013).

4. Wislet-Gendebien, S. et al. Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 23, 392–402 (2005).

5. Brazelton, T. R., Rossi, F. M., Keshet, G. I. & Blau, H. M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290, 1775–1779 (2000).

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological and stem cell therapy of stroke in animal models: Do they accurately reflect the response of humans?;Experimental Neurology;2024-06

2. Simple thermal treatment to improve the MRI and magnetic hyperthermia performance of hybrid iron Oxide-Mesoporous silica nanocarriers;Journal of Molecular Liquids;2024-03

3. Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products;Cytotherapy;2024-02

4. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off‐the‐shelf versatile tumor delivery vehicle;Medicinal Research Reviews;2024-02

5. Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities;Biomolecules;2023-12-20